Everoglob 0.75mg Tablet

Everoglob 0.75mg Tablet

Explore detailed information about Everoglob 0.75mg Tablet, a medication containing Everolimus (0.75mg) from the trusted Globela Pharma Pvt Ltd brand. Discover its primary uses for Breast cancer,Prevention of organ rejection in transplant patients,Lung cancer,Pancreatic cancer,Kidney cancer and delve deeper into its specific details to understand how Everoglob 0.75mg Tablet can play a role in your health and well-being. Add it to your wishlist or compare it with other products.

Information about Everoglob 0.75mg Tablet (Brand: Globela Pharma Pvt Ltd) - Uses: Breast cancer,Prevention of organ rejection in transplant patients,Lung cancer,Pancreatic cancer,Kidney cancer

Wishlist Add to cart

  • MRP: ₹ 1182
  • Packing: 30.0 tablets in 1 strip
  • Salt Combination: Everolimus (0.75mg)
  • Brand: Globela Pharma Pvt Ltd
  • Uses: Breast cancer,Prevention of organ rejection in transplant patients,Lung cancer,Pancreatic cancer,Kidney cancer

Description

  • Everoglob 0.75mg Tablet is used for the prevention of organ rejection in transplant patients
  • It regulates the body’s immune response, so the body can accept the new organ
  • It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney
  • Everoglob 0.75mg Tablet must be taken in a dose and duration as per the prescription
  • It can be taken with or without food but make sure to take it at about the same time every day
  • An overdose of this medicine may have serious side effects on the body.
  • The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection
  • If any of the side effects persist or bother you, consult the doctor immediately
  • Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.)
  • Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.
  • Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease
  • Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment
  • During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body
  • It may affect male or female fertility, so consult the doctor if you are planning to have a child.

Cautions

Liver: CAUTION: Everoglob 0.75mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Everoglob 0.75mg Tablet may be needed. Please consult your doctor. Use of Everoglob 0.75mg Tablet is not recommended in patients with severe liver disease.
Kidney: SAFE IF PRESCRIBED: Everoglob 0.75mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everoglob 0.75mg Tablet is recommended.
Driving: UNSAFE: Everoglob 0.75mg Tablet may cause side effects which could affect your ability to drive.^As fatigue is a common side effect with Everoglob 0.75mg Tablet and this may affect your ability to drive
Breast feeding: CONSULT YOUR DOCTOR: Everoglob 0.75mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency: CONSULT YOUR DOCTOR: Everoglob 0.75mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol: CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Everoglob 0.75mg Tablet. Please consult your doctor.
Drug Action: Immunosuppressant- mTOR inhibitors
Therapeutic class: ANTI NEOPLASTICS
Habit Forming: No
Chemical Class: Macrolide Lactams

Uses

Uses of Everoglob 0.75mg Tablet

  • In Prevention of organ rejection in transplant patients Everoglob 0.75mg Tablet is used with other medications to prevent organ transplant rejection
  • Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc
  • This medicine reduces the activity of a person's own immune system and prevents any such rejection.
Missed Doses
N/A

FAQs

Frequestly asked Questions

Side Effects

Common and Known Side effects of Everoglob 0.75mg Tablet
  • Decreased appetite
  • Increased glucose level in blood
  • Pneumonitis
  • Hypercholesterolemia (high cholesterol)
  • Increased aspartate aminotransferase
  • Decreased white blood cell count (lymphocytes)
  • Lymphopenia
  • Increased alanine aminotransferase
  • Increased triglyceride level in blood
  • Joint pain
  • Pleural effusion
  • Pulmonary edema
  • Rash
  • Diarrhea
  • Infection
  • Breathlessness
  • Stomatitis (Inflammation of the mouth)
  • Fatigue
  • Anemia (low number of red blood cells)
  • Low blood platelets
  • Decreased potassium level in blood
  • Weight loss
  • Taste change

Reviews

Add your review




Alternate Medicines


Certican 0.75mg Tablet

MRP: ₹ 2876

Packing: 10.0 tablets in 1 strip

Salts: Everolimus (0.75mg)

Brand: Novartis India Ltd